Psoriasis Clinical Trial

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Summary

The primary objectives of this study are to evaluate the safety & efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.

View Full Description

Full Description

Same as above.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of moderate to severe plaque psoriasis, defined as 3% - 20% treatable body surface area
Overall Disease Severity of at least 3 (moderate)

Exclusion Criteria:

Surface area involvement too large (>20% BSA)
Psoriasis involving only the scalp, groin, axillae, and/or other intertriginous areas

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

305

Study ID:

NCT00658788

Recruitment Status:

Completed

Sponsor:

Galderma R&D

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 12 Locations for this study

See Locations Near You

Therapeutics Clinical Research
San Diego California, 92123, United States
MedaPhase, Inc.
Newnan Georgia, 30263, United States
Gwinnett Clinical Research Center, Inc
Snellville Georgia, 30078, United States
Hudson Dermatology
Evansville Indiana, 47714, United States
Mount Sinai Department of Dermatology
New York New York, 10029, United States
Northeastern Ohio Universities College of Medicine
Warren Ohio, 44483, United States
Central Sooner Research
Norman Oklahoma, 73069, United States
J&J Studies, Inc
College Station Texas, 77840, United States
Suzanne Bruce and Associates, PA
Houston Texas, 75390, United States
Virginia Clinical Research, Inc
Norfolk Virginia, 23507, United States
Dermatology Associates of Seattle, PLLC
Seattle Washington, 98101, United States
Madison Skin and Research, Inc
Madison Wisconsin, 53719, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

305

Study ID:

NCT00658788

Recruitment Status:

Completed

Sponsor:


Galderma R&D

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider